ReShape Lifesciences Inc. RSLS
3.92 0.00 (+0.00%)
At closeAug 14, 2025, 4:00 PM EDT
2.80 Day range 4.65
4.09 52-week range 29.00
- YTD
- -99.12%
- 1 year
- -99.62%
Revenue & Expenses
Latest period ending Dec 31, 2024 · select a line to chart its full history
Income statement
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 8.01M | 8.68M | 11.24M | 13.60M | 11.30M | |
| 5.06M | 5.55M | 6.80M | 8.35M | 6.26M | |
| -7.73M | -15.38M | -46.35M | -57.88M | -12.46M | |
| -7.13M | -11.39M | -46.21M | -63.15M | -21.63M | |
| -345.75 | -2,771.75 | -157,905.00 | -419,006.50 | -401,650.00 |
Balance sheet
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 793.00K | 4.56M | 3.96M | 22.82M | 3.01M | |
| 4.79M | 10.66M | 11.14M | 52.53M | 37.06M | |
| 5.05M | 4.00M | 7.48M | 8.20M | 22.57M | |
| 967.00K | 262.00K | 171.00K | 279.00K | 13.25M | |
| -253.00K | 6.66M | 3.66M | 44.33M | 14.49M |
Cash flow
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| -4.43M | -16.96M | -21.90M | -15.38M | -8.55M | |
| 677.00K | 17.57M | 3.13M | 33.30M | 11.07M | |
| -3.77M | 604.00K | -18.86M | 19.81M | 22.00K |